Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Update

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Jul 29, 2021 7:48pm

107 Views

Post# 33630039

RE:RE:Update

hotinfo wrote:

PTBailey wrote:

Not a NR but an update on present status, warrants and PAH

https://claritasinvestors.com/index.php?%2Ftopic%2F1011-phone-con-drewbob-29-july%2F&tab=comments&fbclid=IwAR37rDVGgU_DyD1Ef5Ai2iGUy9Pvyf9b0m_lgf-WSaloCtHRGeniJC5dusE#comment-3416

in the article ....

The warrant numbers will remain the same

The exercise price of the warrants will remain the same.

The numbers of warrants required to be exercised to buy one share will be 20.

Which essentially means that in the B Warrants for example, you pay $1.30 to buy one share.
that does not reflect my TD statement od holdings.

i had 300,000 , now i have 15,000 so the warrant numbers did not remain the same ... right ?